GENE ONLINE|News &
Opinion
Blog

ASCO21
Extracting Clinical Information from Cancer Genomics
2021-06-10
New IO Targets and Resistance Mechanisms of Immune Checkpoint-Based Therapies
2021-06-10
#ASCO21: Large Cohort Study by Foundation Medicine and Collaborators Reveal Disparities in Precision Cancer Care
2021-06-09
Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
2021-06-09
Day 3 ASCO 2021 Roundup: Lynparza, Keytruda and Novartis’ Radioligand Therapy Take Honors in Plenary Session
2021-06-09
ASCO21: Current Issues with CAR T Cells for Hematologic Malignancies
2021-06-08
Day 2 ASCO 2021 Roundup: Focus on Equity in Cancer Care, Highlights from Breast Cancer and Gastrointestinal Cancer Studies
2021-06-06
Day 1 ASCO 2021 Roundup: Combating Lung Cancer, Hematologic Malignancies and Advanced Solid Tumors
2021-06-05
LATEST
Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
Amgen Acquires Teneobio to Snag New Class of Antibody Therapies
2021-07-31
Takeda Signs New Deal with PeptiDream Spending Billions to Develop Neuromuscular Disease Drugs
2021-07-30
The Evolution of Cytokine Therapies for a Broad Spectrum of Disorders
2021-07-30
PerkinElmer Makes its Biggest Buy Yet Forking Out $5.25 Billion for Latest Acquisition
2021-07-30
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
Scroll to Top

Subscribe To Our News

Keep yourself updated at all times!